Can a kidney drug stop acute injury from becoming chronic?
Disease control
Not yet recruiting
This trial tests whether finerenone, a drug already used for chronic kidney disease, is safe and tolerable for people hospitalized with acute kidney injury (AKI). About 72 adults with moderate-to-severe AKI will receive either finerenone or a placebo once daily for up to 45 days,…
Phase: NA • Sponsor: Jean-Maxime Côté • Aim: Disease control
Last updated Aug 22, 2026 00:00 UTC